Literature DB >> 31521636

Melatonin, protocatechuic acid and hydroxytyrosol effects on vitagenes system against alpha-synuclein toxicity.

Marta Gallardo-Fernández1, Ruth Hornedo-Ortega2, Ana B Cerezo3, Ana M Troncoso4, M Carmen García-Parrilla5.   

Abstract

Preventing the abnormal assembly of α-synuclein (α-Syn) and the correct modulation of vitagenes system exercise strong neuroprotective effects. It has been reported that melatonin (MEL), protocatechuic acid (PCA) and hydroxytyrosol (HT) reduce α-Syn toxicity. Their effect on the vitagenes system of PC12 cells have not been explored yet. These bioactive can cross the blood brain barrier (BBB). Therefore, this work aims to evaluate the inhibitory and destabilising capacities of MEL, PCA, HT, and their combinations on α-Syn kinetics and effects on vitagenes system (sirtuin-1 (SIRT-1), sirtuin-2 (SIRT-2), heme oxygenase (HO-1) and heat shock protein 70 (Hsp-70)). In vitro techniques (Thioflavin T (ThT), Transmission Electronic Microscopy (TEM), electrophoresis, MTT assay and qPCR) were used. Compounds, both individually and simultaneously were able to decrease the toxicity induced by α-Syn. Concurrently, occurrence of PCA (100 μM) +HT (100 μM) showed the highest inhibitory effect against α-Syn fibril formation and destabilisation of α-Syn fibrils (88 and 62%, respectively). Moreover, these compounds increased the expression of SIRT-2, HO-1 and Hsp70, contributing to a neuroprotective effect. In addition, the most important result is the increase on the expression of SIRT-2 caused by the combination of MEL + HT + PCA in the absence of α-Syn fibrils.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hydroxytyrosol; Melatonin; Parkinson's disease; Protocatechuic acid; Vitagenes system; α-Synuclein

Mesh:

Substances:

Year:  2019        PMID: 31521636     DOI: 10.1016/j.fct.2019.110817

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

Review 1.  Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson's Disease.

Authors:  Zhengjie Yang; Xiaona Zhang; Chengqian Li; Song Chi; Anmu Xie
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

Review 2.  Hydroxytyrosol in Foods: Analysis, Food Sources, EU Dietary Intake, and Potential Uses.

Authors:  Marta Gallardo-Fernández; Marina Gonzalez-Ramirez; Ana B Cerezo; Ana M Troncoso; M Carmen Garcia-Parrilla
Journal:  Foods       Date:  2022-08-06

3.  Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson's disease.

Authors:  Yu-Chen Yan; Zhi-Heng Xu; Jian Wang; Wen-Bo Yu
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

4.  Hydroxytyrosol Decreases LPS- and α-Synuclein-Induced Microglial Activation In Vitro.

Authors:  Marta Gallardo-Fernández; Ruth Hornedo-Ortega; Isabel M Alonso-Bellido; José A Rodríguez-Gómez; Ana M Troncoso; M Carmen García-Parrilla; José L Venero; Ana M Espinosa-Oliva; Rocío M de Pablos
Journal:  Antioxidants (Basel)       Date:  2019-12-31

Review 5.  Contribution of Berry Polyphenols to the Human Metabolome.

Authors:  Preeti Chandra; Atul S Rathore; Kristine L Kay; Jessica L Everhart; Peter Curtis; Britt Burton-Freeman; Aedin Cassidy; Colin D Kay
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

Review 6.  Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins.

Authors:  Vladimir I Muronetz; Kseniya Barinova; Sofia Kudryavtseva; Maria Medvedeva; Aleksandra Melnikova; Irina Sevostyanova; Pavel Semenyuk; Yulia Stroylova; Matej Sova
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.